Total Payments
$83,076
2024 Payments
$5,729
Companies
55
Transactions
1,034
Medicare Patients
3,718
Medicare Billing
$271,751
Payment Breakdown by Category
Other$35,255 (42.4%)
Food & Beverage$32,837 (39.5%)
Consulting$5,950 (7.2%)
Travel$5,632 (6.8%)
Research$2,787 (3.4%)
Education$614.26 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,255 | 22 | 42.4% |
| Food and Beverage | $32,837 | 948 | 39.5% |
| Consulting Fee | $5,950 | 3 | 7.2% |
| Travel and Lodging | $5,632 | 20 | 6.8% |
| Unspecified | $2,787 | 7 | 3.4% |
| Education | $614.26 | 34 | 0.7% |
Payments by Type
General
$80,289
1,027 transactions
Research
$2,787
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $37,243 | 109 | $0 (2023) |
| Amgen Inc. | $9,371 | 90 | $0 (2024) |
| Esperion Therapeutics, Inc. | $5,526 | 26 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $4,339 | 70 | $0 (2022) |
| Novo Nordisk Inc | $4,122 | 132 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,012 | 68 | $0 (2024) |
| ModernaTX, Inc. | $2,195 | 5 | $0 (2023) |
| ABBVIE INC. | $2,128 | 109 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $1,788 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,618 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,729 | 139 | Lexicon Pharmaceuticals, Inc. ($1,788) |
| 2023 | $4,953 | 122 | ModernaTX, Inc. ($2,195) |
| 2022 | $3,360 | 130 | ABBVIE INC. ($650.95) |
| 2021 | $9,265 | 181 | Esperion Therapeutics, Inc. ($5,053) |
| 2020 | $8,653 | 125 | Amarin Pharma Inc. ($6,111) |
| 2019 | $16,912 | 122 | Amarin Pharma Inc. ($13,485) |
| 2018 | $21,724 | 112 | Amarin Pharma Inc. ($10,115) |
| 2017 | $12,481 | 103 | Amarin Pharma Inc. ($7,127) |
All Payment Transactions
1,034 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $28.30 | General |
| 11/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/15/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/01/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, PENBRAYA | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | AIMMUNE THERAPEUTICS, INC. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: ALLERGY | ||||||
| 10/25/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $470.22 | Research |
| Study: A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older | ||||||
| 10/25/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $237.63 | Research |
| Study: A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older | ||||||
| 10/25/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $211.08 | Research |
| Study: A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older | ||||||
| 10/25/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $80.00 | Research |
| Study: A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: PAIN | ||||||
| 10/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LX9211 | Lexicon Pharmaceuticals, Inc. | $1,788 | 3 |
| A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older | SANOFI PASTEUR INC. | $998.93 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 662 | 1,132 | $161,442 | $54,343 |
| 2022 | 17 | 842 | 1,364 | $201,763 | $65,653 |
| 2021 | 19 | 998 | 1,540 | $225,881 | $72,149 |
| 2020 | 24 | 1,216 | 1,857 | $292,790 | $79,606 |
Total Patients
3,718
Total Services
5,893
Medicare Billing
$271,751
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 275 | $75,900 | $24,524 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 147 | $27,048 | $9,143 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 55 | 55 | $16,170 | $7,361 | 45.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 38 | $14,136 | $5,245 | 37.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 15 | 24 | $4,998 | $1,440 | 28.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 125 | 185 | $1,480 | $1,438 | 97.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $3,040 | $1,367 | 45.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 73 | 91 | $4,550 | $1,235 | 27.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 31 | $3,410 | $1,139 | 33.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $2,400 | $645.86 | 26.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 52 | $3,120 | $489.72 | 15.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $870.00 | $151.09 | 17.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 168 | $4,200 | $139.04 | 3.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 12 | $120.00 | $26.40 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 169 | 311 | $85,836 | $26,798 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 203 | $37,352 | $13,732 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 56 | 56 | $16,464 | $7,750 | 47.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 56 | $20,832 | $7,257 | 34.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 16 | $8,480 | $2,347 | 27.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 33 | 45 | $4,950 | $1,785 | 36.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 18 | $3,672 | $1,017 | 27.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 64 | 79 | $3,950 | $962.78 | 24.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $2,080 | $891.02 | 42.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 79 | 81 | $4,698 | $790.93 | 16.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 151 | 251 | $2,008 | $721.87 | 35.9% |
About Dr. Manohar Jethani, MD
Dr. Manohar Jethani, MD is a Family Medicine healthcare provider based in Berwyn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366529505.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manohar Jethani, MD has received a total of $83,076 in payments from pharmaceutical and medical device companies, with $5,729 received in 2024. These payments were reported across 1,034 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,255).
As a Medicare-enrolled provider, Jethani has provided services to 3,718 Medicare beneficiaries, totaling 5,893 services with total Medicare billing of $271,751. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Berwyn, IL
- Active Since 11/01/2006
- Last Updated 11/03/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1366529505
Products in Payments
- Vascepa (Drug) $37,243
- Repatha (Biological) $7,912
- NEXLIZET (Drug) $5,038
- XARELTO (Drug) $2,660
- FARXIGA (Drug) $1,848
- INVOKANA (Drug) $1,673
- Ozempic (Drug) $1,296
- JARDIANCE (Drug) $938.90
- EVENITY (Biological) $684.59
- BYDUREON (Drug) $626.05
- TRULICITY (Drug) $600.51
- VRAYLAR (Drug) $572.42
- ENTRESTO (Drug) $562.73
- UBRELVY (Drug) $517.06
- RYBELSUS (Drug) $512.26
- Kerendia (Drug) $495.16
- NEXLETOL (Drug) $487.42
- Saxenda (Drug) $485.34
- Yupelri (Drug) $461.98
- YUPELRI (Drug) $446.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Berwyn
Dr. Ricardo Perez, M.d, M.D
Family Medicine — Payments: $4,087
Family Medicine $4,087
Matthew Hsieh, M.d, M.D
Family Medicine — Payments: $3,852
Family Medicine $3,852
Ms. Magdaline Piatek, Md, MD
Family Medicine — Payments: $3,711
Family Medicine $3,711
Michael Gershberg, M.d, M.D
Family Medicine — Payments: $2,743
Family Medicine $2,743
John Lawson, Do, DO
Family Medicine — Payments: $1,546
Family Medicine $1,546
Sheila Berndt, M.d, M.D
Family Medicine — Payments: $1,316
Family Medicine $1,316